A Study of BMS-986449 With and Without Nivolumab in Participants With Advanced Solid Tumors
Status:
Not yet recruiting
Trial end date:
2027-07-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to evaluate the safety and efficacy of BMS-986449 alone and in
combination with nivolumab in participants with advanced solid tumors.